XML 14 R5.htm IDEA: XBRL DOCUMENT v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Beginning balance, Shares at Dec. 31, 2024   12,197,615    
Beginning balance at Dec. 31, 2024 $ 5,675 $ 2 $ 240,487 $ (234,814)
Stock-based compensation expense 1,342   1,342  
Net income (loss) (11,031)     (11,031)
Ending balance, Shares at Mar. 31, 2025   12,197,615    
Ending balance at Mar. 31, 2025 (4,014) $ 2 241,829 (245,845)
Beginning balance, Shares at Dec. 31, 2025   12,858,047    
Beginning balance at Dec. 31, 2025 42,014 $ 2 247,005 (204,993)
Issuance of common stock and pre-funded warrants in Registered Direct Offering, net of issuance costs $ 10,360   10,360  
Issuance of common stock and pre-funded warrants in Registered Direct Offering, net of issuance costs, Shares   1,666,679    
Issuance of common stock from option exercises, Shares 0      
Issuance of common stock from RSU vesting, Shares   104,737    
Stock-based compensation expense $ 1,548   1,548  
Net income (loss) (7,609)     (7,609)
Ending balance, Shares at Mar. 31, 2026   14,629,463    
Ending balance at Mar. 31, 2026 $ 46,313 $ 2 $ 258,913 $ (212,602)